Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)

Completed · Phase 3 · Has a placebo group

Conditions studied: Diabetic Peripheral Neuropathy

In brief

The intent of this study is to treat subjects with painful Diabetic Peripheral Neuropathy (DPN) who also have pain on walking and to determine whether or not pregabalin demonstrates improvement relative to placebo on the following: reducing DPN pain, reducing pain on walking, and providing other benefits associated with daily activities and quality of life.

Key facts

Study ID
NCT01474772
Run by
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
People needed
217
Starts
2011-10-01
Expected to finish
2013-07-01
Last updated by the study team
2021-01-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.